# A Novel Role for the Small Molecule Cinnamaldehyde in Protecting Against P. gingivalis–Induced Endothelial Dysfunction in Mice: Involvement of PPARγ/Akt/eNOS and Nrf2/ARE Signaling

**Authors:** Chethan Sampath, Bhavyasri Gaddam, Aaliyah C. Gray, Sasanka S. Chukkapalli, Pandu R. Gangula

PMC · DOI: 10.3390/antiox15020243 · Antioxidants · 2026-02-12

## TL;DR

Cinnamaldehyde protects against vascular damage caused by a harmful bacteria and high-fat diet in mice by restoring key signaling pathways.

## Contribution

This study identifies cinnamaldehyde as a novel protective agent against Pg-induced endothelial dysfunction through PPARγ/Akt/eNOS and Nrf2/ARE signaling.

## Key findings

- Pg infection combined with a high-fat diet caused severe metabolic and vascular dysfunction in mice.
- Cinnamaldehyde supplementation restored metabolic health and improved vascular function by activating PPARγ and Nrf2 pathways.
- Cinnamaldehyde enhanced eNOS phosphorylation and normalized endothelial-dependent vasorelaxation.

## Abstract

Background: Cardiovascular disease (CVD) remains the leading global cause of mortality, with endothelial dysfunction as an early driver of pathology. Periodontal disease (PD) and its pathogen Porphyromonas gingivalis (Pg) are increasingly associated with metabolic disturbances and vascular injury, yet the combined impact of microbial and dietary stressors has not been mechanistically defined. Methods: In this 24-week study, mice were subjected to chronic Pg infection with or without a high-fat diet (HFD). Metabolic profiling, cytokine analyses, molecular signaling assessments, and ex vivo vascular reactivity studies were performed to evaluate systemic and vascular outcomes. Results: Pg infection induced metabolic alterations and vascular inflammation, while HFD alone caused obesity, insulin resistance, dyslipidemia, and impaired endothelial relaxation. Combined Pg infection and HFD produced the most severe phenotype, with synergistically elevated cytokines, heightened TLR4/NF-κB activation, marked suppression of PPARγ and Nrf2 signaling, reduced eNOS expression, and diminished nitric oxide bioavailability. Cinnamaldehyde (CNM) supplementation improved metabolic indices, reduced inflammatory cytokines, restored PPARγ and Nrf2 activation, enhanced Akt-mediated eNOS phosphorylation, and normalized endothelial-dependent vasorelaxation. Conclusions: Pg infection and HFD act as synergistic metabolic and vascular stressors that accelerate endothelial dysfunction through coordinated disruption of PPARγ/Akt/eNOS and Nrf2 pathways, while CNM provides substantial protective effects.

## Linked entities

- **Genes:** PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207], NOS3 (nitric oxide synthase 3) [NCBI Gene 4846], GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551], TLR4 (toll like receptor 4) [NCBI Gene 7099], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790]
- **Chemicals:** cinnamaldehyde (PubChem CID 637511), doxorubicin (PubChem CID 31703)
- **Diseases:** cardiovascular disease (MONDO:0004995), periodontal disease (MONDO:0002635), obesity (MONDO:0011122), dyslipidemia (MONDO:0002525)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Spp1 (secreted phosphoprotein 1) [NCBI Gene 20750] {aka 2AR, Apl-1, BNSP, BSPI, Bsp, ETA-1}, Adm (adrenomedullin) [NCBI Gene 11535] {aka AM}, Il3 (interleukin 3) [NCBI Gene 16187] {aka BPA, Csfmu, HCGF, Il-3, MCGF, PSF}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Nos1 (nitric oxide synthase 1, neuronal) [NCBI Gene 18125] {aka 2310005C01Rik, N-NOS, NC-NOS, NO, NOS, NOS-I}, Csf2 (colony stimulating factor 2 (granulocyte-macrophage)) [NCBI Gene 12981] {aka CSF, Csfgm, GMCSF, Gm-CSf, MGI-IGM}, Nos3 (nitric oxide synthase 3, endothelial cell) [NCBI Gene 18127] {aka 2310065A03Rik, Nos-3, eNOS, ecNOS}, Csf1 (colony stimulating factor 1 (macrophage)) [NCBI Gene 12977] {aka BAP025, Csfm, MCSF, Mhdabap25, PG-M-CSF, op}, Igf1 (insulin-like growth factor 1) [NCBI Gene 16000] {aka C730016P09Rik, Igf-1, Igf-I}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Nosip (nitric oxide synthase interacting protein) [NCBI Gene 66394] {aka 2310061K06Rik, CGI-25}, Gsk3b (glycogen synthase kinase 3 beta) [NCBI Gene 56637] {aka 7330414F15Rik, 8430431H08Rik, GSK-3, GSK-3beta, GSK3}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Gch1 (GTP cyclohydrolase 1) [NCBI Gene 14528] {aka GTP-CH, GTP-CH-I, GTPCH, Gch}, Dhfr (dihydrofolate reductase) [NCBI Gene 13361] {aka 8430436I03Rik}, Saa (serum amyloid A cluster) [NCBI Gene 111345], Keap1 (kelch-like ECH-associated protein 1) [NCBI Gene 50868] {aka INRF2, mKIAA0132}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Il1a (interleukin 1 alpha) [NCBI Gene 16175] {aka Il-1a}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Il5 (interleukin 5) [NCBI Gene 16191] {aka Il-5}, Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}
- **Diseases:** autonomic neuropathy (MESH:D009422), gingival bleeding (MESH:D005884), atheroma (MESH:D058226), glucose (MESH:D018149), vascular and lipid abnormalities (MESH:D011017), PD (MESH:D010510), hepatic infection (MESH:D056486), amyloid (MESH:C000718787), Type 2 diabetes mellitus (MESH:D003924), periodontal bacterial infections (MESH:D001424), adiposity (MESH:D018205), vascular dysfunction (MESH:D002561), vascular injury (MESH:D057772), bone loss (MESH:D001847), alveolar bone loss (MESH:D016301), toxicity (MESH:D064420), weight (MESH:D015431), insulin (MESH:D007333), P. gingivalis infection (MESH:D016720), Infected (MESH:D007239), CVD (MESH:D002318), hypertension (MESH:D006973), atherosclerosis (MESH:D050197), attachment loss (MESH:D017622), metabolic dysregulation (MESH:D021081), ND (MESH:C537354), metabolic disease (MESH:D008659), weight gain (MESH:D015430), organ dysfunction (MESH:D009102), Obesity (MESH:D009765), bleeding (MESH:D006470), nonalcoholic fatty liver disease (MESH:D065626), Diabetic (MESH:D003920), Endothelial dysfunction (MESH:D014652), endothelial impairment (MESH:D020141), dyslipidemia (MESH:D050171), coronary heart disease (MESH:D003327), injury to (MESH:D014947), periodontal (MESH:D010518), Inflammatory (MESH:D007249), tooth loss (MESH:D016388), hyperlipidemia (MESH:D006949), fibrosis (MESH:D005355), metabolic disturbances (MESH:D024821), Hyperglycemia (MESH:D006943)
- **Chemicals:** Glucose (MESH:D005947), ROS (MESH:D017382), KCl (MESH:D011189), LPS (MESH:D008070), lipid (MESH:D008055), CMC (MESH:D002266), CO2 (MESH:D002245), bicinchoninic acid (MESH:C047117), L-arginine (MESH:D001120), carbohydrate (MESH:D002241), trimethoprim (MESH:D014295), nitrite (MESH:D009573), BH4 (MESH:C003402), KH2PO4 (-), superoxide (MESH:D013481), NaHCO3 (MESH:D017693), sulfamethoxazole (MESH:D013420), NO (MESH:D009569), cholesterol (MESH:D002784), Blood glucose (MESH:D001786), hemin (MESH:D006427), NE (MESH:D009638), CaCl2 (MESH:D002122), sodium dodecyl sulfate (MESH:D012967), free fatty acids (MESH:D005230), CNM (MESH:C012843), glycogen (MESH:D006003), TRIzol (MESH:C411644), ACh (MESH:D000109), essential oil (MESH:D009822), Peridex (MESH:C010882), luminal (MESH:D010634), triglyceride (MESH:D014280), mineral oil (MESH:D008899), nitrogen (MESH:D009584), Nitrate (MESH:D009566), salt (MESH:D012492), Fat (MESH:D005223), menadione (MESH:D024483), NaCl (MESH:D012965)
- **Species:** Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Homo sapiens (human, species) [taxon 9606], Porphyromonas gingivalis (species) [taxon 837], Cinnamomum verum (Ceylon cinnamon, species) [taxon 128608], Pg [taxon 1985360], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), W83 — Homo sapiens (Human), Glioblastoma, Cancer cell line (CVCL_C6IZ)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938466/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938466/full.md

## References

67 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938466/full.md

---
Source: https://tomesphere.com/paper/PMC12938466